Michael Jones

Michael Jones is an experienced finance professional with a robust background in accounting and financial reporting. Currently, Michael serves as Corporate Controller at Peptilogics, a position held since January 2022. Prior to this, Michael was the Controller at Cognition Therapeutics, Inc. from March 2020 to December 2021, and the Director of Accounting and Finance - Assistant Controller at BlueRock Therapeutics from September 2018 to March 2020. Michael's extensive experience also includes significant roles at PTC Therapeutics, Inc., where responsibilities spanned from Director, Accounting & Financial Reporting to Manager, External Financial Reporting, along with six years at Ernst & Young as Manager, Assurance Services. Educational qualifications include a Master of Accountancy in Financial Accounting from Rutgers Business School and a Bachelor of Science in Management with a concentration in Accounting from Boston College, graduating Magna Cum Laude.